Chembond Chemicals Limited Earnings Summary — Q1 FY2027
Chembond Chemicals Reports 52% YoY Profit Surge in Q1 FY2027 Despite Sequential Softening
Quarterly Business Intelligence
AI Quarterly Scorecard™
Computed deterministically from the last 10 reported quarters.
Quarterly Business Momentum
- Revenue declined 14.7% sequentially in Q1 FY2027.
- Revenue of ₹86 Cr is 32.3% higher year-on-year.
- Revenue has compounded at 15.9% annualised over the last 10 quarters.
- Net profit of ₹10 Cr is 52.2% above the same quarter last year.
- Profit growth is outpacing revenue growth, pointing to positive operating leverage.
- Net profit has compounded at 30.6% annualised across the period.
- Operating margin stands at 13.1% in Q1 FY2027.
- Operating margin expanded by 22 bps year-on-year.
- Over the last two years operating margin has expanded by 171 bps.
- PBT margin is 14.8%.
- Expense growth of 31.9% remained below revenue growth of 32.3%.
- Operating profit of ₹11 Cr is 34.6% higher year-on-year.
- Operating leverage continues to improve.
- 4 of the last 5 measured quarters delivered year-on-year revenue growth.
- Overall quarterly business momentum scores 65/100 (Healthy) on the latest 10 quarters.
- Business momentum remains positive heading into the next quarter.
Quarterly Financials
Last 10 Reported Quarters • All figures in ₹ Crore • Margins in %
| Metric | Trend | Latest Q1 FY2027 | Q4 FY2026 | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q4 FY2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | Improving | 86 | 101 | 86 | 73 | 65 | 78 | 75 | 75 | 64 | — |
| Expenses | Improving | 75 | 86 | 74 | 62 | 57 | 66 | 60 | 67 | 57 | — |
| Operating Profit | Improving | 11 | 16 | 12 | 11 | 8 | 12 | 14 | 8 | 7 | — |
| Operating Margin | Improving | 13.1% | 15.7% | 14.3% | 14.6% | 12.9% | 15.7% | 19.2% | 10.5% | 11.4% | — |
| Other Income | Accelerating | 3 | -0 | 1 | 0 | 3 | 2 | 0 | 2 | 2 | — |
| Interest | Improving | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |
| Depreciation | Volatile | 1 | 2 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | — |
| Profit Before Tax | Improving | 13 | 14 | 12 | 10 | 10 | 12 | 13 | 9 | 8 | — |
| Tax | Improving | 3 | 2 | 2 | 2 | 4 | 3 | 3 | 2 | 2 | — |
| Net Profit | Improving | 10 | 12 | 10 | 7 | 6 | 9 | 10 | 7 | 6 | — |
| Net Margin | Improving | 11.0% | 11.6% | 11.3% | 9.9% | 9.6% | 11.3% | 13.3% | 9.2% | 8.7% | — |
Key Takeaways
- Revenue from operations grew by 32.27% year-on-year to ₹8,648.22 lakhs, showing strong annual expansion but a 14.7% sequential decline.
- Consolidated Net Profit for the quarter ended June 30, 2026, stood at ₹954.99 lakhs, compared to ₹627.01 lakhs in the same period last year.
- The company maintains a single business segment strategy focusing primarily on the manufacture of Specialty Chemicals.
- Other expenses decreased sequentially from ₹1,607.87 lakhs to ₹1,111.16 lakhs, helping to protect margins despite lower revenue.
- Cost of materials consumed remains the largest expense component at ₹3,897.06 lakhs, or roughly 45% of revenue from operations.
- Two step-down foreign subsidiaries in Thailand and Malaysia contributed ₹144.36 lakhs to revenue and ₹40.00 lakhs to net profit.
- The board approved the transition to the tax structure prescribed under Section 200 of the Income Tax Act for most entities.
- Earnings per share increased significantly on a YoY basis from ₹2.33 to ₹3.54.
Management Guidance
The company has not provided specific forward-looking revenue or profit guidance figures in the current filing but continues to focus on its core Specialty Chemicals segment.
Sentiment Shift
Stable
Year-on-year performance shows robust growth in both top and bottom lines, though sequential data reflects a seasonal or business cycle cooling compared to the high-water mark of Mar-2026.
Outlook
The outlook appears positive based on the substantial year-on-year expansion of the specialty chemicals business and improved profitability margins, despite typical quarterly volatility in raw material costs.
From the Annual Report (Key Quotes)
“The group is primarily engaged in the manufacture of Specialty Chemicals, which... is considered as a single business segment.”
“Based on our review... nothing has come to our attention that causes us to believe that the accompanying Statement... contains any material misstatement.”
“The figures for the quarter ended 31st March, 2026 are balancing figures between audited published figures for the financial year... and the unaudited published figures for the nine months.”
Official Quarterly Documents
Ask AI about this quarter
This summary is AI-generated from Chembond Chemicals Limited's latest quarterly filing and earnings call. For informational purposes only — not investment advice.